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Extracellular adenosine 5´-triphosphate
(ATP) acting on purinergic (P2) receptors
regulates a variety of functions, using trans-
duction pathways that are dependent on the
type of the P2-receptor and on the type of
cells where the action occurs (1,2). For exam-
ple, in the nervous system, ATP is co-released
with neurotransmitters by exocytosis to mod-
ulate the synaptic transmission via the activa-
tion of P2X-receptor cation channels (3).
Macrophages and mast cells express a differ-
ent functional type of P2X-receptor that
changes its ionic selectivity when exposed to
extracellular ATP (4). In this type of receptor,
first designated P2Z and later recognized as
P2X7, the formation of a nonselective cation
channel is followed by a progressive perme-
abilization of the cell membrane to ions of
larger molecular weight and ﬁnally leading to
cell lysis (5). This distinctive second mode of
action involving an apparent increase in pore
diameter has been the focus of many studies
(5–10). P2 receptors have been classified in
two different classes: the ionotropic P2X,
which forms a nonselective cation channel
when activated by an agonist, and the
metabotropic G-protein–coupled P2Y (11).
Structurally, P2X receptors are constituted by
the assemblage of subunits, each one with
two transmembrane domains (12,13),
whereas P2Y has the typical structure of a G-
protein–coupled receptor with seven mem-
brane-spanning domains (13). Seven types of
the P2X class of P2 receptors have been cloned
(P2X1-P2X7) and are distinguished pharmaco-
logically in two groups on the basis of sensitiv-
ity to the ATP congener αβ-ATP. A third
group, the P2X7 receptors, is distinguished
functionally by ionic conductance (14).
The P2X7 activity was first identified in
mast cells and macrophages and was sug-
gested to have a role in cytolysis and apop-
totic death in cells of the immune system
(15,16). P2X7 was then cloned from the rat
brain (6), where it is found in the microglia
(17). Its presence has been documented in
other cell types such as human fibroblasts
(18) and hepatocytes (19), and in the cell
lines CHO-K1 (9) and GH4C1 (28).
Pharmacological studies identified a charac-
teristic higher affinity of P2X7 to the ATP
congener 2´-3´-O-(benzoyl-4-benzoyl)-ATP
(BzATP) than to ATP itself, and revealed a
sensitivity to the ionic environment in the
kinetics of cell permeabilization (21). The
finding that the replacement of extracellular
ionic sodium by the larger ion N-methyl-D-
glucamine (NMDG) facilitates the permeabi-
lization mode of the activated receptor,
causing a delay or inhibition of cell lysis (5),
has been widely used in the functional char-
acterization of the P2X7 (21). 
It is well known that toxins synthesized
by a variety of organisms can selectively bind
to ion conduction channels, altering their
functional properties and leading to toxicity.
The heterotrophic estuarine dinoflagellate
Pfiesteria piscicida Steidinger & Burkholder
was discovered in 1991 by Burkholder and
co-workers (22) and has been implicated as
the causative agent of major ﬁsh kills and ﬁsh
disease in the two largest U.S. mainland estu-
aries (the Albemarle–Pamlico of North
Carolina and Chesapeake Bay in Maryland)
(23). A second toxic Pﬁesteria species has sub-
sequently been identified (among a number
of organisms morphologically similar to P.
piscicida, termed “Pﬁesteria-like” or “Pﬁesteria
look-alike” organisms) from ﬁsh-kill/ﬁsh-dis-
ease events in aquaculture and coastal areas
from Delaware to the Gulf of Mexico (23).
The health hazards attributed to this organ-
ism (24–26) led to the need to characterize
bioactive substances produced by P. piscicida
capable of causing adverse effects. Research to
fully characterize the chemical structure and
biological effects of this putative toxin is a
current challenge. P. piscicida produces a
bioactive substance that induces cytotoxicity
in GH4C1 rat pituitary cells and at nontoxic
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concentrations induces a c-fos luciferase
reporter gene (27). The expression of c-fos in
neural cells is often associated with elevated
cytosolic free calcium [Ca2+]i (28).
Recently we identified the presence of
P2X7 receptor expression in GH4C1 rat pitu-
itary cells and provided evidence for a role of
this receptor type to mediate the action of the
putative Pﬁesteria toxin (pPfTx) in the induc-
tion of c-fos luciferase (20). Here we investi-
gated the ionic properties of the P2X7 receptor
in GH4C1 cells, and the activation of these
characteristic ionic conductances by the
pPfTx. We found that GH4C1 cells have
ionotropic purinergic receptors with pharma-
cologic and functional properties consistent
with the P2X7 subtype and that pPfTx mimics
the kinetics of cell permeabilization by ATP.
Material and Methods
Cell Culture
Clonal GH4C1 cells were maintained in
monolayer cultures in Ham’s F10 medium
supplemented with 15% horse serum and
2.5% fetal bovine serum (F10+) in a water-sat-
urated atmosphere of 5% CO2 and 95% air at
37 ± 1°C. Before experiments, cells were har-
vested from one donor culture dish with
0.02% EDTA and reseeded on glass coverslips
at a density of approximately 200,000
cells/cm2. The cells were grown for 2–5 days,
with change of medium each second day. Only
cultures with less than 10 passages were used.
Chemicals
Culture medium and sera were purchased from
Gibco (Grand Island, NY, USA). ATP, oxi-
dized ATP (oxATP), and BzATP were pur-
chased from Sigma (St. Louis, MO, USA).
Piridoxalphosphate-6-azophenyl-2´-4´-disul-
fonic acid (PPADS) was from Research
Biochemical International (Natick, MA, USA).
The ﬂuorescent dyes Fura-2/AM, Fura-2 pen-
tapotassium salt and YO-PRO-1 (quinolinium,
4-[(3-methyl-2(3H)-benzoxazolylidene)
methyl]-1-[3-(triethylammonio)propyl]-,
diiodide) were from Molecular Probes (Eugene,
OR, USA). Putative toxin was isolated from
ﬁsh-killing cultures of P. piscicida precisely as
described (28).
Calcium Analysis
GH4C1 cells plated in monolayer on glass
coverslips were loaded with Fura-2 just
before the experiment. Cells were washed
twice with Hepes-buffered saline Hanks’ bal-
anced salt solution (HBSS)-II (Hepes 20, D-
glucose 10, NaCl 118, KCl 4.6, CaCl2 0.4
mM, pH 7.2) and incubated with 2 µM
Fura-2/AM in the same buffered saline in a
water-saturated atmosphere of 5% CO2 at
37 ± 1°C for 30 min. Cells were then washed
twice, incubated at room temperature for
20 min, then mounted in a flow-through
chamber (FCSII; Bioptechs Inc., Butler, PA,
USA). Experiments were performed with an
inverted ﬂuorescence microscope [Zeiss 100,
oil immersion Zeiss F-Fluor 40× lens (Carl
Zeiss, Inc., Thornwood, NY, USA)], using
the Attofluor ratio imaging analysis system
(Atto Instruments, Rockville, MD, USA).
Temperature in the chamber was controlled
at 37 ± 1°C and HBSS-II was pumped in a
laminar ﬂow over the cells at a constant rate
of 100 µL/min. Calcium concentration was
calculated by the method of Grynkiewicz
(29). Excitation wavelengths were 340 and
380 nm, and emission intensity was measured
at 510 nm. The cytosolic free calcium con-
centration in single cells was monitored in
real time. At least 30 cells were monitored
simultaneously in each experiment. The val-
ues of cytosolic free calcium from each cell
were averaged after the experiment. We used
the in vitro method of calibration modified
from the Attoﬂuor manual. This method uses
two calibration points, a maximum and a
minimum correspondent respectively to a sat-
urated calcium solution (10 mM CaCl2) and
a solution calcium free (with 10 µM EGTA).
One µM Fura-2 pentapotassium was added
to each solution, which was used to calibrate
the system before each experimental session.
Cell-Permeabilization Analysis
The dye YO-PRO-1, a ﬂuorescent analog of
propidium iodide of 629 Da molecular weight,
was used to detect cell permeabilization (5).
GH4C1 cells plated in monolayer on glass
coverslips were washed twice with HBSS-II
and mounted in the flow-through chamber.
The experiments were performed using an
inverted microscope and the Attoﬂuor imaging
system (described for the calcium analysis
experiments) but in a single wavelength mode
of analysis. A modiﬁed Hepes-buffered saline
solution, made with NMDG substituting for
NaCl (Hepes 20, D-glucose 10, NMDG 118,
KCl 4.6, CaCl2 0.4 mM, pH 7.2) and hence-
forth designated HBSS-YO, was used in the
permeabilization assays (5). HBSS-YO was
pumped in a laminar ﬂow at the rate of 100
µL/min. Test reagents were diluted in 200 µL
HBSS-YO and injected in one of the inﬂows
(see flow-through description below). The
flow of the buffered saline was constant
throughout the experiments. The excitation
wavelength was 460 nm, and emission was
measured at 510 nm. At least 30 cells were
individually monitored simultaneously in real
time during each experiment. Experiments
with BzATP were conducted ﬁve times, ATP
four times, and pPfTx five times. For the
experiments where the inhibition by oxATP
was tested, cells were preincubated with 300
µM of oxATP in F10+ for 40 min in a water-
saturated atmosphere of 5% CO2 at 37 ±
1°C. Cells were then washed twice and
mounted in the flow-through chamber, and
the experiments were performed as above.
Flow-Through System
All of our experiments were completed in a
closed chamber (FCSII; Bioptechs Inc.)
through which a constant laminar ﬂow of the
Hepes-buffered saline was maintained over
the cells. The inflow was fed by one of two
Figure 1. Elevation of the concentration of cytosolic free calcium in the presence of 300 µM BzATP. Cytosolic free
calcium concentrations were calculated following the method of Grynkiewicz (29), using a Kd of 224 nM Fura-2 for
calcium ions. Data are given as the means ± 1 SE of cytosolic free calcium in 30 cells individually monitored simul-
taneously during a single experiment in real time. 
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5Purinergic receptors, a target for putative Pﬁesteria toxins
alternate peristaltic pumps that were digitally
controlled. A check valve just before the
chamber inlet separated the inflows driven
from each pump. The test solution was
injected into a loop inserted into one of the
inﬂows, and was pumped through the cham-
ber when the respective pump was digitally
switched on. Both pumps were set to the ﬂow
rate of 100 µL/min. The temperature in the
chamber was controlled at 37 ± 1°C.
Data Analysis
Values of light emission from individual cells
were averaged and standard errors calculated.
One-way analysis of variance was applied to
the emission data, corresponding to time
points at and just before stimulation by the
test substance.
Results
The action of the P2 receptor agonist BzATP
on [Ca2+]i was investigated in GH4C1 cells
loaded with the ﬂuorescent calcium chelator
Fura-2. The baseline [Ca2+]i was approxi-
mately 200 nM and was elevated to a peak of
390 nM within 3–5 sec after exposure to 300
µM BzATP (Figure 1). [Ca2+]i was main-
tained above 350 nM in the continuous pres-
ence of BzATP and decreased to a plateau of
280 nM when BzATP was washed out.
The permeabilization of the cell mem-
brane to larger ions, a functional characteris-
tic of P2X7 subtype receptors, was next
investigated. GH4C1 cells were mounted in
an inverted microscope under the same con-
ditions of temperature (37 ± 1°C) and ﬂow-
through (100 µL/min) used for the first
experiment with Fura-2. The dye YO-PRO-1
was present in the flowing solution only at
the times indicated in the chart (Figure 2).
The background emission was an average of
20 relative fluorescence units [(RFU), used
to measure the intensity of light emission] in
the absence of the dye and was elevated to
less than 25 RFU when the dye was present.
The mean emission (n = 30 cells) was nearly
25 RFU in the absence of dye. The mean
emission was elevated to less then 40 RFU in
the presence of 5 µM YO-PRO-1 and
returned to 25 RFU after the dye was washed
out. Return of the emission to the initial lev-
els revealed that the fluorescent dye was not
trapped in the cells and indicated that the
cells were not permeable to the dye. When
the dye was delivered simultaneously with
BzATP, a gradual but steady increase of
emission intensity from the cells reached a
level 4-fold higher (96 vs 23 RFU) than the
initial emission. The high emission level was
maintained after the dye and BzATP were
washed out, indicating that the dye had
permeated the cells.
Because BzATP caused both a pharmaco-
logical and functional action characteristic of
P2X7 receptors, we next investigated ATP,
the physiologic agonist of the P2 receptors.
The mean activity of 60 cells that were moni-
tored simultaneously was determined after
normalization by reducing the background
level, which also was measured simultane-
ously (Figure 3). During the periods indi-
cated (Figure 3), the cells were exposed to 5
µM YO-PRO-1 only, or to 5 µM YO-PRO-1
with 200, 400, or 600 µM ATP. There was a
concentration-dependent elevation of light
emission from the cells, demonstrating that
ATP had permeabilized GH4C1 cell mem-
branes to the YO-PRO-1 dye A small
response (an increase of 2-fold the initial
level) was obtained with 200 µM ATP. When
the cells were stimulated with 400 or 600 µM
ATP, there was a 10-fold increase in activity
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Figure 2. Permeabilization of GH4C1 cells to the ﬂuorescent dye YO-PRO-1 in the presence of 300 µM BzATP. Data
are given as the mean RFU ± 1 SD from 35 cells collected in a single real-time experiment for the top tracing and as
the mean RFU ± 1 SD of the background activity from ﬁve selected areas free of cells in the ﬁeld of view. At the time
shown in the chart, 200 µL buffer containing both 300 µM BzATP and 5 µM YO-PRO-1 were being delivered at the
same ﬂow rate.
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Figure 3. Concentration-dependent permeabilization of GH4C1 cells to the ﬂuorescent dye YO-PRO-1 in the presence
of ATP (200, 400, and 600 µM). Data are given as the mean RFU ± 1 SD from 30 cells collected in a single real-time
experiment, after subtracting the background light intensity, which was monitored simultaneously from 5 selected
areas that were free of cells in the ﬁeld of view. At the time shown in the chart, 200 µL of buffer containing both ATP
(200, 400, or 600 µM) and 5 µM YO-PRO-1 were being delivered at the same ﬂow rate.
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relative to the level of the emission plateau
before each treatment.
To reexamine whether P2 receptors
mediate the ATP permeabilization of GH4C1,
we co-administered PPADS, an antagonist of
P2 receptors, and ATP (13). GH4C1 cells
were ﬁrst treated with 300 mM ATP, leading
to accumulation of YO-PRO-1. PPADS given
at 300 µM caused a small increase emission,
and the addition of 300 µM ATP led to a
small increase in dye accumulation. However,
this partial inhibitory effect was reversible, and
after the antagonist was washed out, led to
further accumulation of YO-PRO-1 in the
cells (Figure 4). We next investigated the
action of oxATP, an irreversible and more
selective P2X antagonist (30,31) in GH4C1
cells. Cells were preincubated with 300 µM
oxATP for 30 min in HBSS-II buffered saline,
washed twice, and mounted in the flow-
through chamber using the Hepes buffer with
NMDG substituting NaCl (HBSS-YO), as in
the previous experiments. Pretreatment with
oxATP fully inhibited the accumulation of
YO-PRO-1 in GH4C1 cells exposed to 300
and 600 µM ATP (Figure 5).
To evaluate the role of P2X7 as a potential
target in mediating the toxic effects of
Pﬁesteria, we used a partially puriﬁed fraction
from a toxic culture of the dinoﬂagellate. The
action of pPfTx on cytosolic free calcium was
investigated in GH4C1 cells loaded with the
fluorescent calcium chelator Fura-2. Cells
were mounted on an open coverslip in an
inverted fluorescence microscope, and indi-
vidual cells were monitored under static incu-
bation conditions. With each incremental
addition of the pPfTx caused a gradual sus-
tained elevation of [Ca2+]i that reached near
plateau level in about 90 sec (Figure 6).
Enhanced effects were observed with further
additions, which eventually reached very high
values consistent with cytotoxicity. We next
examined the effect of the pPfTx on GH4C1
cell permeability to YO-PRO-1. Cells were
mounted in the flow-through chamber and
were exposed to 200 µL of 1 µL/100 µL, 2
µL/100 µL, or 4 µL/100 µL pPfTx. The
pPfTx fraction induced the accumulation of
YO-PRO-1 in GH4C1 cells in a concentra-
tion-dependent manner. The intensity of
emission was monitored simultaneously in 60
cells (Figure 7). Exposure of the cells to 1
µL/100 µL caused a small elevation of emis-
sion from 1 to 5 RFU. Exposure to 2 µL/100
µL was repeated, and in both exposures the
average cell emission was elevated with a
reproducible effect that doubled the effect
produced by exposure to 1 µL/100 µL.
Exposure of GH4C1 cells to 4 µL/100 µL led
to an increase of average cell emission to
nearly 58 RFU, an effect 5-fold higher than
that observed from exposure to 2 µL/100 µL
(Figure 7). When we used GH4C1 cells that
previously had been incubated with 300 mM
oxATP, the accumulation of YO-PRO-1 in
GH4C1 cells exposed to 4 µL/100 µL pPfTx
was inhibited (Figure 8). Further exposure to
400 µM ATP also failed to induce the
accumulation of dye in these cells.
Discussion
This research provides evidence for a P2
receptor with the functional characteristics of
the P2X7 type in GH4C1 cells. We used two
signal transduction measurements to identify
this receptor. One was the ability of the selec-
tive agonist BzATP to elevate the cytosolic
free calcium. The other was the subsequent
accumulation of the fluorescent dye YO-
PRO-1 due to the permeabilization of the
cells to larger ions. In GH4C1 cells, BzATP
Figure 4. Permeabilization of GH4C1 cells to the ﬂuorescent dye YO-PRO-1 by ATP, and its partial inhibition by the
purinergic receptor antagonist PPADS. Data are given as the mean RFU ± 1 SD from 30 cells collected in a single real-
time experiment after subtracting the background light intensity, which was monitored simultaneously from five
selected areas free of cells in the ﬁeld of view. Test chemicals and concentrations are shown on the chart and were
always delivered simultaneously with 5 µM YO-PRO-1 in 200 µL buffer at the same ﬂow rate. 
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Figure 5. Permeabilization of GH4C1 cells to the ﬂuorescent dye YO-PRO-1 by ATP, and its inhibition by 300 µM of the
P2X7 antagonist oxATP. Data are given as the mean RFU ± 1 SD from 30 cells individually measured simultaneously in
a single real-time experiment after subtracting the background light intensity, which was monitored simultaneously
from ﬁve selected areas free of cells in the ﬁeld of view. Test chemicals and concentrations are shown on the chart
and were always delivered simultaneously with 5 µM YO-PRO-1 in 200 µL buffer at the same ﬂow rate.
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6Purinergic receptors, a target for putative Pﬁesteria toxins
induced a rapid calcium response that
elevated cytosolic free calcium 2-fold. After
the agonist was washed out, the effect per-
sisted for at least 3 min. When GH4C1 cells
were exposed to BzATP in the presence of the
fluorescent dye YO-PRO-1, a gradual accu-
mulation of the dye in the cells was observed.
The comparison between the effect of BzATP
on the concentration of cytosolic calcium,
and on the accumulation of YO-PRO-1 in
the cells, corresponds to the dynamics of pore
formation characteristic of the purinoceptor
P2X7 (8,12,18). Once activated by an ago-
nist, P2X7 forms a nonselective cation chan-
nel, a characteristic of the ionotropic P2X
class of P2 receptors. The influx of calcium
ions causes the elevation of the cytosolic free
calcium. P2X7 differs from the other mem-
bers of P2X receptors in that its activation
leads to the cell membrane permeability to
larger ions (6). This characteristic has been
studied using fluorescent dyes, particularly
YO-PRO-1 (a derivative of propidium
iodide), which are ions of large molecular
weight with afﬁnity to nucleic acids (5). The
sensitivity to the selective agonist BzATP and
the accumulation of YO-PRO-1 in GH4C1
cells provides evidence for the presence in
these cells of an ionotropic purinoceptor with
the functional characteristics of P2X7.
To further characterize the induction of
cell permeability in GH4C1 cells by the acti-
vation of P2 receptors, we exposed cells to
increasing concentrations of ATP. We
observed that ATP induces the permeability
of GH4C1 cells to YO-PRO-1 in a concen-
tration-dependent manner. The reversibility
of the ATP-induced permeability of the cells
was also shown in this experiment, as the
cells did not accumulate YO-PRO-1 when
they were exposed to the dye both in the
absence of ATP and after observed induction
by 400 µM of the agonist. We next used two
classes of antagonists of P2 receptors to
inhibit the accumulation of YO-PRO-1 in
GH4C1 cells in response to ATP: PPADS, a
reversible antagonist of P2 receptors, and
oxATP, a selective and irreversible inhibitor
of P2X7 (6). PPADS partially inhibited cell
permeability to YO-PRO-1 by ATP, and this
partial inhibition was reversed after the
antagonist was washed out. To investigate
the effect of the P2X7 selective antagonist
oxATP, we pretreated cells with the antago-
nist (30,31). Pretreatment of GH4C1 cells
with oxATP fully inhibited the accumulation
of YO-PRO-1 during exposure to 300 and
600 µM ATP. The ability of a selective
antagonist to prevent the accumulation of
YO-PRO-1 provided a second line of
evidence for functional P2X7 receptors in
GH4C1 cells.
We next investigated the role of the
receptor functionally characterized in this work
as a potential target for the toxicity of the
dinoﬂagellate Pﬁesteria. A bioactive substance
has been identiﬁed in toxic Pﬁesteria cultures
with cytotoxic selectivity to GH4C1 cells based
upon a panel of different cell types (27). We
report here that the pPfTx elevates cytosolic
free calcium in Fura2-loaded GH4C1 cells.
The elevation of calcium is sustained and is
consistent with activation of a membrane
channel that gates calcium. The time course of
elevated cytosolic free calcium is consistent
with activation of P2X7 receptors (32).
Calcium is a second messenger, and one of its
downstream signaling events is among those
factors that induce the immediate response
gene c-fos. For that reason, the sustained
elevation of cytosolic free calcium by pPfTx is
consistent with the induction of the c-fos
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 5 | October 2001 735
Figure 6. Elevation of the concentration of cytosolic free calcium in the presence of putative Pﬁesteria toxin pPfTx.
Cytosolic free calcium concentrations were calculated following the method of Grynkiewicz (29), using a Kd of 224
nM Fura-2 for calcium ions. GH4C1 cells loaded with Fura-2 were treated with increasing amounts of pPfTx, and the
concentration of free cytosolic calcium was monitored individually in 7 cells in real time. Data are given as the activi-
ties (RFU) from individual cells measured simultaneously in an experiment repeated 4 times with similar results. The
pPfTx is expressed as microliters of an assay-guided fraction of a methanol/water extract of toxic Pﬁesteria culture
medium. Exposure of the cells to 15 µL pPfTx led to an increase of cytosolic free calcium, which was enhanced in a
dose-dependent manner by further additions of 5 µL each.
Figure 7. Concentration-dependent permeabilization of GH4C1 cells to the ﬂuorescent dye YO-PRO-1 in the presence
of pPfTx. Data are given as the mean RFU ± 1 SD from 60 cells that were individually measured simultaneously in a
single real-time experiment after subtracting the background light intensity, which was also monitored simultane-
ously from ﬁve selected areas free of cells in the ﬁeld of view. The pPfTx was always delivered simultaneously with
5 µM YO-PRO-1 in 200 µL buffer at the same ﬂow rate. Where indicated, only the dye (without pPfTx) was delivered
in the same manner. 
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luciferase construct in GH4C1 cells, a
downstream response used to originally iden-
tify the action of this substance (20,27).
Activation of P2X7 receptors leads to strong
induction of additional transcription factors as
well, including nuclear factor (NF)-kappaB
and the nuclear factor of activated T cells
(NFAT), both of which are associated with
cytokine production (33). NFAT is induced
rapidly and requires the entry of extracellular
calcium. NFAT has a unique DNA binding
region, yet binds cooperatively with the
Fos/Jun heterodimer to the regulation region
of the interleukin-2 gene (34). By contrast,
NF-kappaB is induced more slowly and may
require more downstream signaling events
(35). Subsequent to elevating cytosolic free
calcium, pPfTx induced the permeabilization
of GH4C1 cells to YO-PRO-1. This action of
pPfTx is consistent with its cytotoxic effect
(27) and the decreased c-fos luciferase activity
(20). The permeabilizing effect of pPfTx in
GH4C1 cells was completely inhibited by
oxATP. These results provide an additional
line of evidence that the previously described
cytotoxic effect of pPfTx (27) likely is
mediated by P2X7 receptors (20). 
Deﬁning the role for P2 receptors has been
hampered partly because few, if any, natural
specific agonists have been identified for
purinergic receptors. One toxin that also shows
a strong cytotoxic response in GH4C1 and
other cell types is maitotoxin (36,37).
Although the primary target for maitotoxin has
not been identified, it does elevate cytosolic
calcium in GH4C1 cells by activating a
calcium-dependent membrane depolarization
(38,39), one that appears to involve chloride
conductances (40). Maitotoxin induces c-fos
luciferase and at higher concentrations cyto-
toxicity in GH4C1 cells expressing this con-
struct (41). Maitotoxin has been found to
activate a cytolytic pore in several other cell
types; however, overexpressing P2X7 receptors
in HEK-292 cells, which leads to substantial
BzATP responses, fails to enhance the response
to maitotoxin (42,43). These results indicate
that P2X7 is not a primary target for maito-
toxin, although activation of a cytolytic pore is
a likely downstream response. Thus pPfTx
may prove to be a unique pharmacological
probe for P2 receptors. More deﬁnitive charac-
terization of pPfTx will require larger-scale
production of toxic Pfiesteria for structural
resolution of the toxin.
A role of P2X7 receptors in the action of
Pﬁestera toxin is of interest, considering that
this toxic dinoflagellate has been reported to
cause a range of health impacts in both ﬁnﬁsh
and humans (22–26). The effects linked to
Pﬁesteria toxicity may be related to an inﬂam-
matory response, either in macrophages in
the periphery or microglia in brain tissue.
Implication of P2X7 receptors as a potential
target for the bioactive substance produced
by toxic P. piscicida provides a common
basis for the investigation of symptoms that
previously have been regarded as unrelated,
such as ulcers in menhaden and cognitive
dysfunction in humans.
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